Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases. (P9-12.005)
Abstract
OBJECTIVE
Migraine affects about 14.4% of the population causing substantial burden. Our objective was to describe the populations of individuals diagnosed with migraine headache with regards to diagnosis and review healthcare service utilization across various categories.
BACKGROUND
.
DESIGN/METHODS
We reviewed recent (8/2018 - 7/2021) medical and pharmacy data from Health Verity for N=187,780. The final sample included 76,684 migraine cases matched to (matching criteria included demographic, geographic, comorbidity, and time-based variables) 76,684 non-migraine controls.
RESULTS
Within the migraine group, 68.4% were female (44.7 yrs, SD=13.9) vs. 69.7% female in the control group (45.6 yrs, SD=14.6). At baseline, migraine cases had higher rates of all-cause healthcare service utilization in each utilization subgroup: Migraine group was more likely to be hospitalized (10.4% vs. 4.5%*), have an Emergency Department (ED) visit (30.3% vs. 11.9%*), have a primary care physician visit (88.1% vs. 54.4%*), have a neurology visit (20.3% vs. 2.0%*), have higher overall use of other medical services, and have higher prescription fill rates (21.3 fills vs 9.53*) (*= p < 0.05). Similar differences were noted during the follow-up period, with migraine cases having higher rates of all-cause healthcare service utilization in each utilization subgroup. Notably, Neurology visits were 12.2 times more likely among the migraine case group compared to the control group, followed by other…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.